| Issue Date | Title | Author(s) |
| 2018 | Dual role of Par‐4 in abrogation of EMT and switching on mesenchymal to epithelial transition (MET) in metastatic pancreatic cancer cells | Katoch, Archana; Suklabaidya, Sujit; Chakraborty, Souneek; Nayak, Debasis; Rasool, Reyaz U.; Sharma, Deepak; Mukherjee, Debaraj; Faheem, Mir M.; Kumar, Anmol; Sharma, Parduman R.; Senapati, Shantibhusan; Kumar, Lekha D.; Goswami, Anindya |
| 2023-04 | Insight into the Role of Phytochemicals in the Treatment of Triple-Negative Breast Cancer | Maru, Devangkumar; Kumar, Anmol |
| 2021-12-31 | A necessary role for increased biglycan expression during L1-mediated colon cancer progression | Saha, Arka; Cheriyamundath, Sanith; Kumar, Anmol; Gavert, Nancy; Brabletz, Thomas; Ben-Ze’ev, Avri |
| 2022-03-01 | Targeting ferroptosis pathways: a novel strategy for cancer therapy | Maru, Devangkumar; Hothi, Akhil; Bagariya, Chintan; Kumar, Anmol |
| 2019 | Vimentin activation in early apoptotic ncer cells errands survival pathways during DNA damage inducer CPT treatment in colon carcinoma model | Chakraborty, Souneek; Kumar, Aviral; Faheem, Mir Mohd; Katoch, Archana; Kumar, Anmol; Jamwal, Vijay Lakshmi; Nayak, Debasis; Golani, Aparna; Rasool, Reyaz Ur; Ahmad, Syed Mudabir; Jose, Jedy; Kumar, Rakesh; Gandhi, Sumit G; Kumar, Lekha Dinesh; Goswami, Anindya |
